clinical trials
trial name
conditions
enrollment ends
Evaluation of the safety and efficacy of a new innate immunotherapy for treatment of sarcoids in the horse
sarcoids
January 1, 2027
Immunotherapy for the treatment of eyelid and corneolimbal squamous cell carcinoma in the horse
squamous cell carcinoma
May 1, 2027
Immunotherapy for the treatment of genital squamous cell carcinoma in the horse
squamous cell carcinoma
June 1, 2026
Immunotherapy for treatment of corneolimbal squamous cell carcinoma in the horse
ocular squamous cell carcinoma
July 1, 2026